39] on day time 5; p 0.05). Open in a separate window Figure 1 Effect of the anti-RSV mAb (motavizumab) on pulmonary function. RANTES, IFN- and GM-CSF. Overall, cytokine concentrations were reduced serum than in BAL samples. By day time 28, only KC CZC-25146 was recognized in BAL specimens at Continue Reading